# Forensic Dossier: Study Forensics: Gene therapy elevating Klotho protein extends lifespan in mice

**Run ID:** `mechfix_study-forensics-024_Claude_Haiku_a896d4`  
**Task:** study-forensics-024 | study_forensics | hard | study_forensics  
**Timestamp:** 2026-04-08T16:41:15.500111+00:00  
**Task Family:** mechanism_vs_evidence  
**Trap Type:** animal_to_human_overreach  
**Ambiguity:** low  

## Executive Summary

**Agents tested:** Claude Haiku
**Winner:** Claude Haiku — **71.5/100** (margin: 0.0)
**Failure modes:** decorative_uncertainty, missed_key_insight, unsupported_conclusion, unsupported_intermediate_step
**Forensic flags:** 2
**Consistency findings:** 8
**Answer convergence:** all agents agree

## Score Matrix

| Agent | Correctness | Support Strength | Structural Reaso | Assumption Disci | Uncertainty Hand | Alternative Hypo | Self Monitoring  | Insight Depth | Mechanism Qualit | Communication Ef | **Total** |
|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|
| Claude Haiku | 30.0/30 | 0.0/8 | 4.8/8 | 3.3/6 | 3.3/6 | 5.0/6 | 5.6/8 | 8.0/8 | 3.0/10 | 8.5/10 | **71.5/100** |

## Study Forensics Audit

### Claude Haiku

**Classification:** `mechanism_vs_evidence` [+] (gold: `mechanism_vs_evidence`)
**Finding Recall:** 67%
**Matched Findings:** mechanism_not_demonstrated, conclusion_exceeds_results
**Missed Findings:** unsupported_generalization
**Extra Findings:** evidence_matches_claim, cautious_scope_control, none_or_minor, decorative_uncertainty, correlation_as_causation

## Reasoning Integrity Audit

### Claude Haiku
**Classification:** Correct but brittle reasoning
**Load-bearing steps:** 0 / 7

## Mechanism Analysis

### Claude Haiku
| Aspect | Status |
|--------|--------|
| Concept named | :x: none |
| Mechanism described | :white_check_mark: (1 sentence(s)) |
| Grounded to case | :x: (0 sentence(s)) |

**Missing:** concept not named, mechanism not grounded to case data

## Grounding Audit

### Claude Haiku
Conclusion claims: 1
- Direct support: 0
- Indirect support: 0
- Unsupported: 1
- Contradicted: 0

**Unsupported claims:**
- "mechanism_vs_evidence"


## Forensic Flags

### Claude Haiku

- **[MAJOR]** `unsupported_leap`: Correct answer with weak support chain — final answer may be an unsupported leap
- **[MODERATE]** `unsupported_conclusion_claims`: 1/1 conclusion claims lack step support
  - `final_answer`: "mechanism_vs_evidence"


## Evidence Map

### Claude Haiku

**Correctness:** 30.0/30
  - (+) `final_answer`: "mechanism_vs_evidence"
    _Agent's answer for correctness check_
  - Note: Exact match

**Support Strength:** 0.0/8
  - (-) `final_answer`: "mechanism_vs_evidence"
    _Conclusion not supported by steps_
  - Note: Support classification: 0 load-bearing, 0 supporting, 0 mentioned / 7
  - Note: Reasoning graph: conclusion not well grounded

**Structural Reasoning:** 4.8/8
  - (+) `steps[1]`: "2. CONCLUSION TIER IDENTIFICATION: The text explicitly states 'this gene therapy could help build a healthier society by"
    _Most informative reasoning step_
  - Note: 7 reasoning steps
  - Note: Low step utility: 0/7 steps contribute

**Assumption Discipline:** 3.3/6
  - (+) `assumptions[2]`: "Lifespan extension, muscle strength, bone density, and cognitive improvements were measured in mice"
    _Most substantive assumption_
  - Note: 6/6 substantive assumptions
  - Note: Many assumptions (6)

**Uncertainty Handling:** 3.3/6
  - (+) `uncertainties[2]`: "Whether the viral vector used is the same one proposed for human use, or if 'suitable delivery method' implies a differe"
    _Most substantive uncertainty_
  - (+) `confidence`: "confidence: 0.88"
    _Stated confidence level_
  - (-) `uncertainties[3]`: "The magnitude of effect sizes and statistical significance (not provided in the summary)"
    _Listed but never addressed in reasoning_
  - (-) `uncertainties[4]`: "Whether this is a peer-reviewed publication or a press release; the summary does not cite a source"
    _Listed but never addressed in reasoning_
  - Note: 5 uncertainties (5 substantive)
  - Note: 2 decorative uncertainty(ies)

**Alternative Hypothesis Quality:** 5.0/6
  - (+) `alternative_hypotheses[0]`: "SOLID: If the text were framed as 'researchers demonstrated in mice that Klotho gene therapy extends lifespan and improv"
    _Most substantive alternative hypothesis_
  - Note: 3 alternative hypotheses considered
  - Note: 1/3 include rejection reasoning

**Self Monitoring Quality:** 5.6/8
  - (+) `self_check[1]`: "Did I miss that this might be solid? CHECK: No. A solid study would report mouse results as mouse results and explicitly"
    _Most substantive self-verification step_
  - Note: 5 self-check items
  - Note: Self-check quality: 0 deep, 5 arithmetic, 0 fluff

**Mechanism Quality:** 3.0/10
  - (+) `(mechanism analysis)`: "5. MECHANISM CLAIM: The text implies a mechanistic pathway (Klotho → neurogenesis and immune activation → healthspan/lif"
    _Mechanism description_
  - Note: Describes mechanism but does not name concept

**Communication Efficiency:** 8.5/10
  - Note: Signal density: 0.68, 692 words

**Insight Depth:** 8.0/8
  - (+) `(output text)`: "e study is conducted in mice (animal model). this is tier 2 evidence. 2."
    _Insight 'animal model' matched (exact)_
  - Note: Key insights: 2 full / 2


## Failure Analysis

### Claude Haiku

**MODERATE:**
- **Unsupported Conclusion** `[MEDIUM CONFIDENCE]`: Final answer lacks load-bearing or supporting step grounding
  - `final_answer`: "mechanism_vs_evidence"
  - _Impacts: support_strength_
- **Unsupported Intermediate Step** `[MEDIUM CONFIDENCE]`: No reasoning step is load-bearing — final answer lacks traceable derivation
  - `final_answer`: "mechanism_vs_evidence"
  - _Impacts: support_strength, structural_reasoning_
- **Missed Key Insight** `[MEDIUM CONFIDENCE]`: Missed expected finding: unsupported_generalization
  - `(task expectation)`: "Expected: unsupported_generalization"
  - _Impacts: insight_depth_

**STYLISTIC:**
- **Decorative Uncertainty** `[HEURISTIC]`: Uncertainty 'The magnitude of effect sizes and statistical significance (...' is listed but not addressed
  - `uncertainties[3]`: "The magnitude of effect sizes and statistical significance (not provided in the summary)"
  - _Impacts: uncertainty_handling_
- **Decorative Uncertainty** `[HEURISTIC]`: Uncertainty 'Whether this is a peer-reviewed publication or a press relea...' is listed but not addressed
  - `uncertainties[4]`: "Whether this is a peer-reviewed publication or a press release; the summary does not cite a source"
  - _Impacts: uncertainty_handling_


## Consistency & Grounding Audit

### Claude Haiku

- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 1 has low overlap with final answer (1/31 content words)
  - `key_claims[0]`: "MAIN EPISTEMIC ISSUE: The text bridges from animal evidence (mice) to human therapeutic potential (c"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 2 has low overlap with final answer (1/13 content words)
  - `key_claims[1]`: "PATENT FILING AS SIGNAL: The filing of patents for human applications signals commercial intent but "
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 3 has low overlap with final answer (0/15 content words)
  - `key_claims[2]`: "MECHANISTIC PLAUSIBILITY: The observed mechanisms (neurogenesis, immune activation) are plausible an"
- **[WARN]** `[HEURISTIC]` `decorative_uncertainty`: Uncertainty 4 appears decorative — not addressed in reasoning or self-check
  - `uncertainties[3]`: "The magnitude of effect sizes and statistical significance (not provided in the summary)"
- **[WARN]** `[HEURISTIC]` `decorative_uncertainty`: Uncertainty 5 appears decorative — not addressed in reasoning or self-check
  - `uncertainties[4]`: "Whether this is a peer-reviewed publication or a press release; the summary does not cite a source"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 1 is stated without rejection reasoning
  - `alternative_hypotheses[0]`: "SOLID: If the text were framed as 'researchers demonstrated in mice that Klotho gene therapy extends"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 2 is stated without rejection reasoning
  - `alternative_hypotheses[1]`: "OVERCLAIM: If the text claimed 'this therapy will extend human lifespan by 15–20%' without hedging, "
- **[NOTE]** `[MEDIUM CONFIDENCE]` `mechanism_gap`: Causal mechanism described but underlying concept not named
  - `final_answer`: "mechanism_vs_evidence"


## Agent Profiles

### Claude Haiku (claude-haiku-4-5-20251001)
**Parse OK:** True | **Latency:** 15660ms

**Final Answer:** mechanism_vs_evidence

**Confidence:** 0.88

**Assumptions:**
- The study was conducted in mice (middle-aged, not aged to death)
- The intervention was a viral vector gene therapy delivering secreted Klotho
- Lifespan extension, muscle strength, bone density, and cognitive improvements were measured in mice
- Neurogenesis and immune markers were assessed in mouse hippocampus
- No human trials are mentioned or implied to have been conducted
- The text presents this as a preclinical finding with future therapeutic potential

**Reasoning Steps:**
1. 1. EVIDENCE TIER IDENTIFICATION: The study is conducted in mice (animal model). This is Tier 2 evidence.
2. 2. CONCLUSION TIER IDENTIFICATION: The text explicitly states 'this gene therapy could help build a healthier society by combating age-related decline' and mentions filing patents for treating human conditions (bone, muscle, aging-related deficits). This implies human therapeutic benefit (Tier 5 conclusion).
3. 3. BRIDGE GAP DETECTION: There is a substantial gap between animal evidence (Tier 2) and human therapeutic claims (Tier 5).
4. 4. HEDGE ANALYSIS: The text uses cautious language ('could help,' 'with a suitable delivery method,' 'suggested that'). However, these hedges acknowledge the gap without closing it. They do not constitute evidence that the therapy will work in humans.
5. 5. MECHANISM CLAIM: The text implies a mechanistic pathway (Klotho → neurogenesis and immune activation → healthspan/lifespan benefits) but this mechanism is demonstrated only in mice, not humans.
6. 6. PATENT FILING: The mention of patents for human applications further signals intent to move to human use, but no human data supports this transition.
7. 7. CONFOUNDERS NOT ADDRESSED: The text does not discuss whether lifespan extension in mice translates to humans, whether the viral vector delivery is safe in humans, or whether the dose/timing would be comparable.

**Key Claims:**
- MAIN EPISTEMIC ISSUE: The text bridges from animal evidence (mice) to human therapeutic potential (combating age-related decline in society) without direct human evidence. Hedging language ('could,' 'with suitable delivery') acknowledges uncertainty but does not provide the evidence needed to support the human claim.
- PATENT FILING AS SIGNAL: The filing of patents for human applications signals commercial intent but does not constitute evidence of human efficacy or safety.
- MECHANISTIC PLAUSIBILITY: The observed mechanisms (neurogenesis, immune activation) are plausible and well-measured in mice, but plausibility in animals does not guarantee translation to humans.

**Alternative Hypotheses:**
- SOLID: If the text were framed as 'researchers demonstrated in mice that Klotho gene therapy extends lifespan and improves markers of healthspan; further research is needed to assess human safety and efficacy,' the claim would stay within the animal evidence tier and be solid.
- OVERCLAIM: If the text claimed 'this therapy will extend human lifespan by 15–20%' without hedging, it would be a direct overclaim. The actual text hedges, so this is less severe.
- CORRELATION_VS_CAUSATION: Not the primary issue here, as the study appears to use experimental manipulation (viral vector delivery), not observational correlation.

**Uncertainties:**
- Whether the mice were followed to natural death or censored at a specific age (affects interpretation of lifespan extension)
- Whether the improvements in muscle, bone, and cognition are independent or secondary to lifespan extension
- Whether the viral vector used is the same one proposed for human use, or if 'suitable delivery method' implies a different approach
- The magnitude of effect sizes and statistical significance (not provided in the summary)
- Whether this is a peer-reviewed publication or a press release; the summary does not cite a source

**Self-Verification:**
- Did I overclassify this as mechanism_vs_evidence? CHECK: Yes, this is correct. The evidence is animal-level, the conclusion is human-therapeutic. The hedges do not close this gap.
- Did I miss that this might be solid? CHECK: No. A solid study would report mouse results as mouse results and explicitly state that human trials are needed. This text implies human benefit ('help build a healthier society').
- Did I confuse hedging with evidence? CHECK: No. I correctly identified that 'could' and 'with suitable delivery' are hedges that acknowledge uncertainty, not evidence that resolves the tier mismatch.
- Is the classification too harsh? CHECK: No. The text explicitly mentions filing patents for human use and suggests societal benefit, which is a human-tier claim. The evidence does not support this tier.
- Did I miss confounders? CHECK: I noted that mouse lifespan extension does not guarantee human benefit, and that delivery method is unspecified. These are appropriate concerns.

**Dimension Scores:**
- Correctness: 30.0/30 `##########`
- Support Strength: 0.0/8 `..........`
- Structural Reasoning: 4.8/8 `######....`
- Assumption Discipline: 3.3/6 `#####.....`
- Uncertainty Handling: 3.3/6 `#####.....`
- Alternative Hypothesis Quality: 5.0/6 `########..`
- Self Monitoring Quality: 5.6/8 `#######...`
- Insight Depth: 8.0/8 `##########`
- Mechanism Quality: 3.0/10 `###.......`
- Communication Efficiency: 8.5/10 `########..`


## Final Verdict

**Solo run: Claude Haiku** scored **71.5/100**.

**Best per dimension:**
- Correctness: Claude Haiku (30.0/30)
- Support Strength: Claude Haiku (0.0/8)
- Structural Reasoning: Claude Haiku (4.8/8)
- Assumption Discipline: Claude Haiku (3.3/6)
- Uncertainty Handling: Claude Haiku (3.3/6)
- Alternative Hypothesis Quality: Claude Haiku (5.0/6)
- Self Monitoring Quality: Claude Haiku (5.6/8)
- Insight Depth: Claude Haiku (8.0/8)
- Mechanism Quality: Claude Haiku (3.0/10)
- Communication Efficiency: Claude Haiku (8.5/10)

**Latency vs Quality:**

| Agent | Latency | Score | Points/sec |
|-------|---------|-------|------------|
| Claude Haiku | 15.7s | 71.5/100 | 4.6 |

Failure modes observed: decorative_uncertainty, missed_key_insight, unsupported_conclusion, unsupported_intermediate_step.
